课题基金 / 基金详情

GLUTAMINE AMIDOTRANSFERASE STRUCTURE/FUNCTION/REGULATION

GLUTAMINE AMIDOTRANSFERASE STRUCTURE/FUNCTION/REGULATION
谷氨酰胺酰胺转移酶结构/功能/调节
批准号:
3484530
负责人:
HOWARD ZALKIN
金额:
$26.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-07-01 至 1997-06-30

项目摘要

项目成果

HOWARD ZALKIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Glutamine amidotransferases are a family of enzymes that utilize the amide of glutamine in biosynthesis. they provide the main route for incorporation of nitrogen into amino acids, purine and pyrimidine nucleotides, amino sugars and coenzymes. There are 3 glutamine amidotransferases in the pathway for purine nucleotide synthesis. Glutamine PRPP amidotransferase catalyzes step 1 and is the key regulatory enzyme in the de novo pathway. The long term objective of this research is to determine basic mechanisms for glutamine amidotransferase catalysis and regulation as well as gene regulation in microorganisms. There are 4 specific aims. (1) Determine mechanisms for regulation of glutamine PRPP amidotransferase. The experiments focus on two regulatory events: nucleotide endproduct inhibition and processing of an NH2-terminal pro-peptide in the Bacillus subtilis enzyme. (2) Determine mechanisms for genetic regulation of Escherichia coli genes involved in the IMP to AMP and GMP branches of the pathway. (3) Determine how purine bases bind to E. coli pur regulon aporepressor and how this binding promotes the specific holorepressor-DNA interactions. (4) Determine mechanisms for transcriptional regulation of the B. subtilis pur operon which encodes the 10 step pathway to IMP and regulation of genes purA, guaA and guaB for the IMP to AMP and GMP branches. Finally, experiments are planned to determine the importance of B. subtilis pur operon gene overlaps in establishing the translational stoichiometry for enzyme synthesis. Purine metabolism has been a fertile area for development of drugs against a variety of diseases. Two inhibitors of glutamine amidotransferases in the purine pathway, acivicin and triciribine have antineoplastic activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DE NOVO PURINE NUCLEOTIDE BIOSYNTHESIS
  • 批准号:
    3305902
  • 项目类别:
  • 资助金额:
    $18.95万
  • 财政年份:
    1992
  • 负责人:
    HOWARD ZALKIN
  • 依托单位:
DE NOVO PURINE NUCLEOTIDE BIOSYNTHESIS
  • 批准号:
    3305904
  • 项目类别:
  • 资助金额:
    $19.31万
  • 财政年份:
    1992
  • 负责人:
    HOWARD ZALKIN
  • 依托单位:
DE NOVO PURINE NUCLEOTIDE BIOSYNTHESIS
  • 批准号:
    2183953
  • 项目类别:
  • 资助金额:
    $20.82万
  • 财政年份:
    1992
  • 负责人:
    HOWARD ZALKIN
  • 依托单位:
DE NOVO PURINE NUCLEOTIDE BIOSYNTHESIS
  • 批准号:
    2183952
  • 项目类别:
  • 资助金额:
    $19.96万
  • 财政年份:
    1992
  • 负责人:
    HOWARD ZALKIN
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: